STOCK TITAN

T. Rowe (NASDAQ: TROW) director gets dividend reinvestment share grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRICE T ROWE GROUP INC director Robert F. MacLellan acquired 206.3598 shares of Common Stock as a fully vested grant under the company’s 2017 Non-Employee Director Equity Plan, tied to dividends on the stock. The shares were credited as dividend reinvestment, bringing his direct holdings to 52,965.8316 shares.

Positive

  • None.

Negative

  • None.
Insider MacLellan Robert F.
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 206.36 $89.03 $18K
Holdings After Transaction: Common Stock — 52,965.832 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares granted 206.3598 shares Dividend reinvestment grant under 2017 Non-Employee Director Equity Plan
Reported price per share $89.03 per share Value used for the Common Stock grant
Holdings after transaction 52,965.8316 shares Director’s direct Common Stock holdings following grant
Acquire transactions 1 transaction Non-derivative grant/award acquisition reported in this Form 4
2017 Non-Employee Director Equity Plan financial
"This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared"
dividend reinvestment shares financial
"These shares were credited as fully-vested dividend reinvestment shares."
Common Stock financial
"with respect to dividends declared by the issuer on it's Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MacLellan Robert F.

(Last)(First)(Middle)
C/O T. ROWE PRICE GROUP, INC.
1307 POINT STREET

(Street)
BALTIMORE MARYLAND 21231

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRICE T ROWE GROUP INC [ TROW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/30/2026A206.3598(1)A$89.0352,965.8316D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. These shares were credited as fully-vested dividend reinvestment shares.
Remarks:
Cheryl L. Emory, Assistant Corporate Secretary, POA for MacLellan, Robert F.03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TROW director Robert F. MacLellan report on this Form 4?

Robert F. MacLellan reported acquiring 206.3598 shares of PRICE T ROWE GROUP INC Common Stock. The shares were granted as fully vested dividend reinvestment shares under the company’s 2017 Non-Employee Director Equity Plan, rather than through an open-market purchase.

Was the TROW Form 4 transaction a market buy or a compensation grant?

The Form 4 for PRICE T ROWE GROUP INC shows a grant/award acquisition, not an open-market buy. MacLellan’s 206.3598 shares were credited as dividend reinvestment shares under the 2017 Non-Employee Director Equity Plan, reflecting compensation-linked reinvested dividends.

How many TROW shares does Robert F. MacLellan hold after this Form 4 transaction?

After receiving the new shares, Robert F. MacLellan directly holds 52,965.8316 shares of PRICE T ROWE GROUP INC Common Stock. This figure includes the 206.3598 fully vested dividend reinvestment shares credited in connection with dividends declared on the company’s Common Stock.

What price per share is reported for the TROW dividend reinvestment grant to MacLellan?

The Form 4 lists a transaction price of $89.03 per share for the 206.3598 Common Stock shares. This price is used for reporting the value of the dividend reinvestment grant under the 2017 Non-Employee Director Equity Plan for non-employee directors.

What is the T. Rowe Price 2017 Non-Employee Director Equity Plan mentioned in MacLellan’s filing?

The 2017 Non-Employee Director Equity Plan is an equity compensation program for PRICE T ROWE GROUP INC’s non-employee directors. Under this plan, dividends on Common Stock can be credited as fully vested dividend reinvestment shares, as occurred in MacLellan’s reported transaction.